ASXC - Asensus Surgical: Surgical Robot Company

• Surgical Robots market will grow at a rapid pace (CAGR of 20.1%) in the future.
• ASXC's Senhance System and other products are achieving regulatory clearances from U.S., Europe, and Asian authorities.
• More hospitals are buying or leasing their robots, and I expect the revenue growth to pick up as hospital activities normalize.
• They are well funded ($118 M cash and short-term investments balance), and should be able to execute a customer base expansion plan.

For further details see: